EU5 Orthobiologics Market Outlook to 2020

  • March 2014
  • -
  • Global Data
  • -
  • 166 pages

EU5 Orthobiologics Market Outlook to 2020

Summary

GlobalData’s new report, "EU5 Orthobiologics Market Outlook to 2020", provides key market data on the EU5 Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories – Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment–based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment–based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Orthobiologics market categories – Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
- 2012 company shares and distribution shares data for each of the market categories.
- Global corporate-level profiles of key companies operating within the EU5 Orthobiologics market.
- Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc., Stryker Corporation and Alphatec Holdings, Inc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table Of Contents

1 Table of Contents
2 Introduction 10
2.1 What Is This Report About? 10
2.2 Orthobiologics Market Segmentation 10
2.3 Definitions of Markets Covered in the Report 11
3 Orthobiologics Market, EU5 12
3.1 Orthobiologics Market, EU5, Revenue ($m), 2005-2020 12
3.2 Orthobiologics Market, EU5, Category Comparison by Revenue ($m), 2005-2020 14
3.3 Orthobiologics Market, EU5, Revenue ($m), 2005-2012 16
3.4 Orthobiologics Market, EU5, Revenue ($m), 2012-2020 18
3.5 Orthobiologics Market, EU5, Volume (Units), 2005-2020 20
3.6 Orthobiologics Market, EU5, Volume (Units), 2005-2012 22
3.7 Orthobiologics Market, EU5, Volume (Units), 2012-2020 24
3.8 Orthobiologics Market, EU5, Company Share by Revenue ($m), 2011-2012 26
4 Orthobiologics Market, France 28
4.1 Orthobiologics Market, France, Revenue ($m), 2005-2012 28
4.2 Orthobiologics Market, France, Revenue ($m), 2012-2020 30
4.2.1 Bone Graft Substitutes Market, France, Revenue ($m), by Segment, 2005-2012 32
4.2.2 Bone Graft Substitutes Market, France, Revenue ($m), by Segment, 2012-2020 34
4.3 Orthobiologics Market, France, Volume (Units), 2005-2012 36
4.4 Orthobiologics Market, France, Volume (Units), 2012-2020 38
4.4.1 Bone Graft Substitutes Market, France, Volume (Units), by Segment, 2005-2012 40
4.4.2 Bone Graft Substitutes Market, France, Volume (Units), by Segment, 2012-2020 42
4.5 Orthobiologics Market, France, Average Price ($), 2005-2020 44
4.6 Orthobiologics Market, France, Distribution Share by Revenue ($m), 2011-2012 46
4.7 Orthobiologics Market, France, Company Share by Revenue ($m), 2011-2012 47
5 Orthobiologics Market, Germany 49
5.1 Orthobiologics Market, Germany, Revenue ($m), 2005-2012 49
5.2 Orthobiologics Market, Germany, Revenue ($m), 2012-2020 51
5.2.1 Bone Graft Substitutes Market, Germany, Revenue ($m), by Segment, 2005-2012 53
5.2.2 Bone Graft Substitutes Market, Germany, Revenue ($m), by Segment, 2012-2020 55
5.3 Orthobiologics Market, Germany, Volume (Units), 2005-2012 57
5.4 Orthobiologics Market, Germany, Volume (Units), 2012-2020 59
5.4.1 Bone Graft Substitutes Market, Germany, Volume (Units), by Segment, 2005-2012 61
5.4.2 Bone Graft Substitutes Market, Germany, Volume (Units), by Segment, 2012-2020 63
5.5 Orthobiologics Market, Germany, Average Price ($), 2005-2020 65
5.6 Orthobiologics Market, Germany, Distribution Share by Revenue ($m), 2011-2012 67
5.7 Orthobiologics Market, Germany, Company Share by Revenue ($m), 2011-2012 68
6 Orthobiologics Market, Italy 70
6.1 Orthobiologics Market, Italy, Revenue ($m), 2005-2012 70
6.2 Orthobiologics Market, Italy, Revenue ($m), 2012-2020 72
6.2.1 Bone Graft Substitutes Market, Italy, Revenue ($m), by Segment, 2005-2012 74
6.2.2 Bone Graft Substitutes Market, Italy, Revenue ($m), by Segment, 2012-2020 76
6.3 Orthobiologics Market, Italy, Volume (Units), 2005-2012 78
6.4 Orthobiologics Market, Italy, Volume (Units), 2012-2020 80
6.4.1 Bone Graft Substitutes Market, Italy, Volume (Units), by Segment, 2005-2012 82
6.4.2 Bone Graft Substitutes Market, Italy, Volume (Units), by Segment, 2012-2020 84
6.5 Orthobiologics Market, Italy, Average Price ($), 2005-2020 86
6.6 Orthobiologics Market, Italy, Distribution Share by Revenue ($m), 2011-2012 88
6.7 Orthobiologics Market, Italy, Company Share by Revenue ($m), 2011-2012 89
7 Orthobiologics Market, Spain 91
7.1 Orthobiologics Market, Spain, Revenue ($m), 2005-2012 91
7.2 Orthobiologics Market, Spain, Revenue ($m), 2012-2020 93
7.2.1 Bone Graft Substitutes Market, Spain, Revenue ($m), by Segment, 2005-2012 95
7.2.2 Bone Graft Substitutes Market, Spain, Revenue ($m), by Segment, 2012-2020 97
7.3 Orthobiologics Market, Spain, Volume (Units), 2005-2012 99
7.4 Orthobiologics Market, Spain, Volume (Units), 2012-2020 101
7.4.1 Bone Graft Substitutes Market, Spain, Volume (Units), by Segment, 2005-2012 103
7.4.2 Bone Graft Substitutes Market, Spain, Volume (Units), by Segment, 2012-2020 105
7.5 Orthobiologics Market, Spain, Average Price ($), 2005-2020 107
7.6 Orthobiologics Market, Spain, Distribution Share by Revenue ($m), 2011-2012 109
7.7 Orthobiologics Market, Spain, Company Share by Revenue ($m), 2011-2012 110
8 Orthobiologics Market, United Kingdom 112
8.1 Orthobiologics Market, United Kingdom, Revenue ($m), 2005-2012 112
8.2 Orthobiologics Market, United Kingdom, Revenue ($m), 2012-2020 114
8.2.1 Bone Graft Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2005-2012 116
8.2.2 Bone Graft Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2012-2020 118
8.3 Orthobiologics Market, United Kingdom, Volume (Units), 2005-2012 120
8.4 Orthobiologics Market, United Kingdom, Volume (Units), 2012-2020 122
8.4.1 Bone Graft Substitutes Market, United Kingdom, Volume (Units), by Segment, 2005-2012 124
8.4.2 Bone Graft Substitutes Market, United Kingdom, Volume (Units), by Segment, 2012-2020 126
8.5 Orthobiologics Market, United Kingdom, Average Price ($), 2005-2020 128
8.6 Orthobiologics Market, United Kingdom, Distribution Share by Revenue ($m), 2011-2012 130
8.7 Orthobiologics Market, United Kingdom, Company Share by Revenue ($m), 2011-2012 131
9 Overview of Key Companies in EU5 Orthobiologics Market 133
9.1 DePuy Companies 133
9.1.1 Company Overview 133
9.2 Medtronic, Inc. 133
9.2.1 Company Overview 133
9.3 Sanofi 133
9.3.1 Company Overview 133
9.4 Biomet, Inc. 134
9.4.1 Company Overview 134
9.5 Stryker Corporation 134
9.5.1 Company Overview 134
9.6 Baxter International Inc. 134
9.6.1 Company Overview 134
9.7 DJO Finance LLC 135
9.7.1 Company Overview 135
9.8 Orthofix International N.V. 135
9.8.1 Company Overview 135
9.9 Wright Medical Group, Inc. 135
9.9.1 Company Overview 135
9.10 Anika Therapeutics, Inc. 136
9.10.1 Company Overview 136
9.11 Seikagaku Corporation 136
9.11.1 Company Overview 136
9.12 Smith and Nephew Plc 137
9.12.1 Company Overview 137
10 Orthobiologics Market Pipeline Products 138
11 Financial Deals Landscape 141
11.1 Asset Transactions 141
11.1.1 Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million 141
11.2 Partnerships 143
11.2.1 Artimplant Enters Into Co-Marketing Agreement With Tiller International Capital 143
11.2.2 aap Implantate Enters Into Licensing Agreement With Medical Technology Company For Injectable Bone Matrix 144
12 Recent Developments 145
12.1 Corporate Communications 145
12.1.1 Dec 05, 2013: TiGenix appoints Gri-Cel CEO Dirk Büscher and COO Jose Terencio to board of directors following strategic investment by Grifols 145
12.1.2 Aug 01, 2013: Artimplant applies for its own bankruptcy 145
12.2 Financial Announcements 146
12.2.1 Nov 05, 2013: TiGenix Business Update and Financial Highlights for Q3 of 2013 146
12.2.2 Aug 20, 2013: TiGenix half year 2013 results 147
12.2.3 Jun 04, 2013: Neuros Medical Announces Pilot Study Results On Electrical Nerve Block Technology 148
12.2.4 May 30, 2013: Artimplant Reports Revenue Of SEK4.4m In Q1 2013 149
12.2.5 May 14, 2013: TiGenix Reports Q1 2013 Results 150
12.2.6 Mar 12, 2013: TiGenix Reports Revenue Of €4.1m In 2012 151
12.2.7 Feb 27, 2013: Artimplant Reports Revenue Of SEK21.1m In 2012 154
12.3 Government and Public Interest 154
12.3.1 Sep 10, 2013: Bone Biologics to Webcast, Live, at RetailInvestorConferences.com on September 12th 154
12.4 Legal And Regulatory 155
12.4.1 Feb 11, 2014: Alphatec Spine Announces Jury Verdict in the OrthoTec Litigation 155
12.5 Other Significant Developments 155
12.5.1 Dec 23, 2013: TiGenix secures EUR 10 million in financing from Kreos Capital 155
12.5.2 Nov 20, 2013: TiGenix Raises EUR 12 million via a private placement of new ordinary shares 156
12.6 Product News 157
12.6.1 Sep 19, 2013: Meniscus Treatment with the BioTissue Scaffold - New research outcomes 157
12.6.2 Mar 19, 2013: Ranier Technology Gets US Patent For Graduated Modulus Technology 157
13 Appendix 158
13.1 Research Methodology 159
13.1.1 Coverage 159
13.1.2 Secondary Research 159
13.1.3 Primary Research 160
13.1.4 Market Modeling and Forecasting 161
13.1.5 Company Share Analysis 164
13.1.6 Distribution Share Analysis 165
13.2 Expert Panel 166
13.3 GlobalData Consulting 166
13.4 Contact Us 166
13.5 Disclaimer 166

1.1 List of Tables

Table 1: Orthobiologics Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2005-2020 13
Table 2: Orthobiologics Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2005-2020 15
Table 3: Orthobiologics Market, EU5, Revenue ($m), Historic, USD Constant, 2005-2012 17
Table 4: Orthobiologics Market, EU5, Revenue ($m), Forecast, USD Constant, 2012-2020 19
Table 5: Orthobiologics Market, EU5, Volume (Units), 2005-2020 21
Table 6: Orthobiologics Market, EU5, Volume (Units), Historic, 2005-2012 23
Table 7: Orthobiologics Market, EU5, Volume (Units), Forecast, 2012-2020 25
Table 8: Orthobiologics Market, EU5, Company Share by Revenue ($m), USD Constant, 2011-2012 27
Table 9: Orthobiologics Market, France, Revenue ($m), USD Constant, Historic, 2005-2012 29
Table 10: Orthobiologics Market, France, Revenue ($m), USD Constant, Forecast, 2012-2020 31
Table 11: Bone Graft Substitutes Market, France, Revenue ($m), USD Constant, Historic, 2005-2012 33
Table 12: Bone Graft Substitutes Market, France, Revenue ($m), USD Constant, Forecast, 2012-2020 35
Table 13: Orthobiologics Market, France, Volume (Units), Historic, 2005-2012 37
Table 14: Orthobiologics Market, France, Volume (Units), Forecast, 2012-2020 39
Table 15: Bone Graft Substitutes Market, France, Volume (Units), Historic, 2005-2012 41
Table 16: Bone Graft Substitutes Market, France, Volume (Units), Forecast, 2012-2020 43
Table 17: Orthobiologics Market, France, Average Price ($), Historic, 2005-2012 44
Table 18: Orthobiologics Market, France, Average Price ($), Forecast, 2012-2020 45
Table 19: Orthobiologics Market, France, Distribution Share by Revenue ($m), USD Constant, 2011-2012 46
Table 20: Orthobiologics Market, France, Company Share by Revenue ($m), USD Constant, 2011-2012 48
Table 21: Orthobiologics Market, Germany, Revenue ($m), USD Constant, Historic, 2005-2012 50
Table 22: Orthobiologics Market, Germany, Revenue ($m), USD Constant, Forecast, 2012-2020 52
Table 23: Bone Graft Substitutes Market, Germany, Revenue ($m), USD Constant, Historic, 2005-2012 54
Table 24: Bone Graft Substitutes Market, Germany, Revenue ($m), USD Constant, Forecast, 2012-2020 56
Table 25: Orthobiologics Market, Germany, Volume (Units), Historic, 2005-2012 58
Table 26: Orthobiologics Market, Germany, Volume (Units), Forecast, 2012-2020 60
Table 27: Bone Graft Substitutes Market, Germany, Volume (Units), Historic, 2005-2012 62
Table 28: Bone Graft Substitutes Market, Germany, Volume (Units), Forecast, 2012-2020 64
Table 29: Orthobiologics Market, Germany, Average Price ($), Historic, 2005-2012 65
Table 30: Orthobiologics Market, Germany, Average Price ($), Forecast, 2012-2020 66
Table 31: Orthobiologics Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2011-2012 67
Table 32: Orthobiologics Market, Germany, Company Share by Revenue ($m), USD Constant, 2011-2012 69
Table 33: Orthobiologics Market, Italy, Revenue ($m), USD Constant, Historic, 2005-2012 71
Table 34: Orthobiologics Market, Italy, Revenue ($m), USD Constant, Forecast, 2012-2020 73
Table 35: Bone Graft Substitutes Market, Italy, Revenue ($m), USD Constant, Historic, 2005-2012 75
Table 36: Bone Graft Substitutes Market, Italy, Revenue ($m), USD Constant, Forecast, 2012-2020 77
Table 37: Orthobiologics Market, Italy, Volume (Units), Historic, 2005-2012 79
Table 38: Orthobiologics Market, Italy, Volume (Units), Forecast, 2012-2020 81
Table 39: Bone Graft Substitutes Market, Italy, Volume (Units), Historic, 2005-2012 83
Table 40: Bone Graft Substitutes Market, Italy, Volume (Units), Forecast, 2012-2020 85
Table 41: Orthobiologics Market, Italy, Average Price ($), Historic, 2005-2012 86
Table 42: Orthobiologics Market, Italy, Average Price ($), Forecast, 2012-2020 87
Table 43: Orthobiologics Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2011-2012 88
Table 44: Orthobiologics Market, Italy, Company Share by Revenue ($m), USD Constant, 2011-2012 90
Table 45: Orthobiologics Market, Spain, Revenue ($m), USD Constant, Historic, 2005-2012 92
Table 46: Orthobiologics Market, Spain, Revenue ($m), USD Constant, Forecast, 2012-2020 94
Table 47: Bone Graft Substitutes Market, Spain, Revenue ($m), USD Constant, Historic, 2005-2012 96
Table 48: Bone Graft Substitutes Market, Spain, Revenue ($m), USD Constant, Forecast, 2012-2020 98
Table 49: Orthobiologics Market, Spain, Volume (Units), Historic, 2005-2012 100
Table 50: Orthobiologics Market, Spain, Volume (Units), Forecast, 2012-2020 102
Table 51: Bone Graft Substitutes Market, Spain, Volume (Units), Historic, 2005-2012 104
Table 52: Bone Graft Substitutes Market, Spain, Volume (Units), Forecast, 2012-2020 106
Table 53: Orthobiologics Market, Spain, Average Price ($), Historic, 2005-2012 107
Table 54: Orthobiologics Market, Spain, Average Price ($), Forecast, 2012-2020 108
Table 55: Orthobiologics Market, Spain, Distribution Share by Revenue ($m), USD Constant, 2011-2012 109
Table 56: Orthobiologics Market, Spain, Company Share by Revenue ($m), USD Constant, 2011-2012 111
Table 57: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2012 113
Table 58: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2012-2020 115
Table 59: Bone Graft Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2012 117
Table 60: Bone Graft Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2012-2020 119
Table 61: Orthobiologics Market, United Kingdom, Volume (Units), Historic, 2005-2012 121
Table 62: Orthobiologics Market, United Kingdom, Volume (Units), Forecast, 2012-2020 123
Table 63: Bone Graft Substitutes Market, United Kingdom, Volume (Units), Historic, 2005-2012 125
Table 64: Bone Graft Substitutes Market, United Kingdom, Volume (Units), Forecast, 2012-2020 127
Table 65: Orthobiologics Market, United Kingdom, Average Price ($), Historic, 2005-2012 128
Table 66: Orthobiologics Market, United Kingdom, Average Price ($), Forecast, 2012-2020 129
Table 67: Orthobiologics Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2011-2012 130
Table 68: Orthobiologics Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2011-2012 132
Table 69: Orthobiologics Market Pipeline Products 138
Table 70: Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million 141
Table 71: Artimplant Enters Into Co-Marketing Agreement With Tiller International Capital 143
Table 72: aap Implantate Enters Into Licensing Agreement With Medical Technology Company For Injectable Bone Matrix 144
Table 73: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 161

1.2 List of Figures
Figure 1: Orthobiologics Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2005-2020 12
Figure 2: Orthobiologics Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2005-2020 14
Figure 3: Orthobiologics Market, EU5, Revenue ($m), Historic, USD Constant, 2005-2012 16
Figure 4: Orthobiologics Market, EU5, Revenue ($m), Forecast, USD Constant, 2012-2020 18
Figure 5: Orthobiologics Market, EU5, Volume (Units), 2005-2020 20
Figure 6: Orthobiologics Market, EU5, Volume (Units), Historic, 2005-2012 22
Figure 7: Orthobiologics Market, EU5, Volume (Units), Forecast, 2012-2020 24
Figure 8: Orthobiologics Market, EU5, Company Share (%), 2012 26
Figure 9: Orthobiologics Market, France, Revenue ($m), USD Constant, Historic, 2005-2012 28
Figure 10: Orthobiologics Market, France, Revenue ($m), USD Constant, Forecast, 2012-2020 30
Figure 11: Bone Graft Substitutes Market, France, Revenue ($m), USD Constant, Historic, 2005-2012 32
Figure 12: Bone Graft Substitutes Market, France, Revenue ($m), USD Constant, Forecast, 2012-2020 34
Figure 13: Orthobiologics Market, France, Volume (Units), Historic, 2005-2012 36
Figure 14: Orthobiologics Market, France, Volume (Units), Forecast, 2012-2020 38
Figure 15: Bone Graft Substitutes Market, France, Volume (Units), Historic, 2005-2012 40
Figure 16: Bone Graft Substitutes Market, France, Volume (Units), Forecast, 2012-2020 42
Figure 17: Orthobiologics Market, France, Company Share (%), 2012 47
Figure 18: Orthobiologics Market, Germany, Revenue ($m), USD Constant, Historic, 2005-2012 49
Figure 19: Orthobiologics Market, Germany, Revenue ($m), USD Constant, Forecast, 2012-2020 51
Figure 20: Bone Graft Substitutes Market, Germany, Revenue ($m), USD Constant, Historic, 2005-2012 53
Figure 21: Bone Graft Substitutes Market, Germany, Revenue ($m), USD Constant, Forecast, 2012-2020 55
Figure 22: Orthobiologics Market, Germany, Volume (Units), Historic, 2005-2012 57
Figure 23: Orthobiologics Market, Germany, Volume (Units), Forecast, 2012-2020 59
Figure 24: Bone Graft Substitutes Market, Germany, Volume (Units), Historic, 2005-2012 61
Figure 25: Bone Graft Substitutes Market, Germany, Volume (Units), Forecast, 2012-2020 63
Figure 26: Orthobiologics Market, Germany, Company Share (%), 2012 68
Figure 27: Orthobiologics Market, Italy, Revenue ($m), USD Constant, Historic, 2005-2012 70
Figure 28: Orthobiologics Market, Italy, Revenue ($m), USD Constant, Forecast, 2012-2020 72
Figure 29: Bone Graft Substitutes Market, Italy, Revenue ($m), USD Constant, Historic, 2005-2012 74
Figure 30: Bone Graft Substitutes Market, Italy, Revenue ($m), USD Constant, Forecast, 2012-2020 76
Figure 31: Orthobiologics Market, Italy, Volume (Units), Historic, 2005-2012 78
Figure 32: Orthobiologics Market, Italy, Volume (Units), Forecast, 2012-2020 80
Figure 33: Bone Graft Substitutes Market, Italy, Volume (Units), Historic, 2005-2012 82
Figure 34: Bone Graft Substitutes Market, Italy, Volume (Units), Forecast, 2012-2020 84
Figure 35: Orthobiologics Market, Italy, Company Share (%), 2012 89
Figure 36: Orthobiologics Market, Spain, Revenue ($m), USD Constant, Historic, 2005-2012 91
Figure 37: Orthobiologics Market, Spain, Revenue ($m), USD Constant, Forecast, 2012-2020 93
Figure 38: Bone Graft Substitutes Market, Spain, Revenue ($m), USD Constant, Historic, 2005-2012 95
Figure 39: Bone Graft Substitutes Market, Spain, Revenue ($m), USD Constant, Forecast, 2012-2020 97
Figure 40: Orthobiologics Market, Spain, Volume (Units), Historic, 2005-2012 99
Figure 41: Orthobiologics Market, Spain, Volume (Units), Forecast, 2012-2020 101
Figure 42: Bone Graft Substitutes Market, Spain, Volume (Units), Historic, 2005-2012 103
Figure 43: Bone Graft Substitutes Market, Spain, Volume (Units), Forecast, 2012-2020 105
Figure 44: Orthobiologics Market, Spain, Company Share (%) 2012 110
Figure 45: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2012 112
Figure 46: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2012-2020 114
Figure 47: Bone Graft Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2012 116
Figure 48: Bone Graft Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2012-2020 118
Figure 49: Orthobiologics Market, United Kingdom, Volume (Units), Historic, 2005-2012 120
Figure 50: Orthobiologics Market, United Kingdom, Volume (Units), Forecast, 2012-2020 122
Figure 51: Bone Graft Substitutes Market, United Kingdom, Volume (Units), Historic, 2005-2012 124
Figure 52: Bone Graft Substitutes Market, United Kingdom, Volume (Units), Forecast, 2012-2020 126
Figure 53: Orthobiologics Market, United Kingdom, Company Share (%), 2012 131
Figure 54: GlobalData Epidemiology-Based Forecasting Model 163
Figure 55: GlobalData Capital Equipment-Based Forecasting Model 164
Figure 56: Primary Interviews by Participant Type (%) 165

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Future Horizons and Growth Strategies in the Global Orthopedics Market 2014: Strategic Assessments of  Leading Suppliers

Future Horizons and Growth Strategies in the Global Orthopedics Market 2014: Strategic Assessments of Leading Suppliers

  • $ 12 500
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $12,500.  Individual company assessments $1,900. A strategic assessment of the competitive environment is unquestionably one of the highest priority management responsibilities, the task ...

Joint Reconstruction and Replacement: Materials, Technologies, and Global Markets

Joint Reconstruction and Replacement: Materials, Technologies, and Global Markets

  • $ 6 650
  • Industry report
  • July 2014
  • by BCC Research

This BCC Research report covers the global joint reconstruction and replacement market, procedures, key growth areas, and quantitative market projections for technologies and devices through 2018. Increasing ...

Global Orthopedic Soft Tissue Repair Devices Market 2014-2018

Global Orthopedic Soft Tissue Repair Devices Market 2014-2018

  • $ 2 500
  • Industry report
  • August 2014
  • by Infiniti Research Limited

About Orthopedic Soft Tissue Repair Devices Orthopedic soft tissues are the mass of cells that connect, support, or surround bones. There are several types of orthopedic soft tissues such as tendons, ligaments, ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.